InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Glickman Mark A. Officer active across 3 companies, notably Aralez Pharmaceuticals Inc.. In total, 4 reports have been logged. History available since 6 December 2022. The latest transaction was disclosed on 7 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations